Table 3.
Clinicopathological characteristics of adenocarcinoma patients with family history of lung cancer (FHLC) versus without family history of lung cancer (non-FHLC).
| FHLC (%) | non- FHLC (%) | P value | |
|---|---|---|---|
| Number of patients | 79 | 490 | NAs |
| Age | 65 ± 9 | 65 ± 10 | 0.366 |
| <50 years | 4 (5) | 34 (7) | 0.535 |
| Sex | |||
| Male | 50 (63) | 294 (60) | |
| Female | 29 (37) | 196 (40) | 0.579 |
| Smokers | 54 (68) | 303(62) | |
| Never smokers | 25 (32) | 187 (38) | 0.266 |
| ppoFEV1.0 (L) | 1.8±0.5 | 1.8±0.6 | 0.912 |
| Asymptomatic | 60 (76) | 372 (76) | |
| Symptomatic | 19 (24) | 118 (24) | 0.995 |
| Diagnosis before surgery | 67 (85) | 415 (85) | 0.979 |
| Operative procedures | |||
| Pneumonectomy | 4 (5) | 23 (5) | |
| Others | 75 (95) | 467 (95) | 0.886 |
| Adjuvant therapy | 39 (49) | 227 (46) | 0.615 |
| Pathological stage of lung cancer | |||
| I, II | 60 (76) | 352 (72) | |
| III, IV | 19 (24) | 138 (28) | 0.448 |
NA, not applicable; MPLC, multiple primary lung cancer.